NCT07745881 Analgesic Effects of Retro-superior Costotransverse Ligament Space Block for Video-assisted Thoracoscopic Surgery
| NCT ID | NCT07745881 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanjing First Hospital, Nanjing Medical University |
| Condition | Nerve Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 130 participants |
| Start Date | 2026-08-05 |
| Primary Completion | 2028-05-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 130 participants in total. It began in 2026-08-05 with a primary completion date of 2028-05-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this clinical trial is to investigate the effects of postoperative analgesia during retro-SCTLB(retro superior costotransverse ligament space block) and TPVB(thoracic paravertebral block) in patients undergoing thoracoscopic radical resection of lung cancer。By comparing the dosage of opioid drugs after surgery, the impact of retro-SCTLB and TPVB on the postoperative analgesic effect was evaluated.
Eligibility Criteria
Inclusion Criteria: * Patients scheduled for thoracoscopic radical lung cancer surgery under general anesthesia； * aged 18-80 years； * BMI 18-30 kg/m²； * ASA classification I-III； Exclusion Criteria: * Allergy to the study drug or local anesthetic; * History of opioid abuse; * Pre-existing skin infection at the puncture site of ITPN or TPVB; * Peripheral infectious neuropathy; * Dysfunction of blood coagulation;
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07745881 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Nerve Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07745881 currently recruiting?
Yes, NCT07745881 is actively recruiting participants. Contact the research team at shantao2021@163.com for enrollment information.
Where is the NCT07745881 trial being conducted?
This trial is being conducted at Nanjing, China.
Who is sponsoring the NCT07745881 clinical trial?
NCT07745881 is sponsored by Nanjing First Hospital, Nanjing Medical University. The trial plans to enroll 130 participants.